Evidence map›Paper›PMID 34901073›Full record

ArticleFrontiers in medicine2021

Elevated Serum Tenascin-C Predicts Mortality in Critically Ill Patients With Multiple Organ Dysfunction.

Yunyu Xu, Nanyang Li, Jiamin Gao, Da Shang, Min Zhang, Xiaoyi Mao, Ruiying Chen, Jianming Zheng, Ying Shan, Mingquan Chen and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. A virological view of tenascin-C in infection.American journal of physiology. Cell physiology · 2023
    Review
  2. Article
  3. Advances on the roles of tenascin-C in cancer.Journal of cell science · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Yunyu XuDivision of Nephrology, Huashan Hospital, Fudan University, Shanghai, China.
Nanyang LiDepartment of Emergency, Huashan Hospital, Fudan University, Shanghai, China.
Jiamin GaoDepartment of Emergency, Huashan Hospital, Fudan University, Shanghai, China.
Da ShangDivision of Nephrology, Huashan Hospital, Fudan University, Shanghai, China.
Min ZhangDivision of Nephrology, Huashan Hospital, Fudan University, Shanghai, China.
Xiaoyi MaoDivision of Nephrology, Huashan Hospital, Fudan University, Shanghai, China.
Ruiying ChenDivision of Nephrology, Huashan Hospital, Fudan University, Shanghai, China.
Jianming ZhengDepartment of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China.
Ying ShanDepartment of Emergency, Huashan Hospital, Fudan University, Shanghai, China.
Mingquan ChenDepartment of Emergency, Huashan Hospital, Fudan University, Shanghai, China.
Qionghong XieDivision of Nephrology, Huashan Hospital, Fudan University, Shanghai, China.
Chuan-Ming HaoDivision of Nephrology, Huashan Hospital, Fudan University, Shanghai, China.
Fudan University · CNHuashan Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkercritically ill patientsmortalitymultiple organ dysfunction (MODS)tenascin-C

Identifiers

PMID34901073
PMCPMC8661593
OpenAlexW3216611411

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.